Clinical Trial

A Multimodal AI Prediction Model for Complications After Transcatheter Closure of Perimembranous VSD in Children

Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this observational study is to develop and validate a multimodal artificial intelligence prediction model for treatment-related complications in children with perimembranous ventricular septal defect (pmVSD) undergoing transcatheter device closure. The main question it aims to answer is: Can an AI model that integrates demographics, laboratory results, electronic health record text, echocardiography reports, chest radiographs, and electrocardiogram accurately predict the risk of complications at the individual patient level? Data will be retrospectively collected from routine clinical care records of pediatric patients who underwent transcatheter closure for pmVSD. Deep learning methods will be used to extract features from text and images to train and validate the prediction model.
Protocol Amendment History 3 changes
notable Primary completion pushed: 2026-06-15 -> 2027-06-01 2026-08-06
minor Completion pushed: 2026-06-15 -> 2027-12-30 2026-08-06
critical Recruitment opened 2026-04-10
Trial Details
NCT Number NCT07375602
Lead Sponsor Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Conditions Congenital Heart Disease (CHD), Ventricular Septal Defects (VSD), Cardiac Catheterization, Postoperative Complications
Enrollment 5,249 participants
Start Date 2026-02-01
Primary Completion 2027-06-01 (estimated)
Study Completion 2027-12-30 (estimated)
Updated on ClinicalTrials.gov 2026-08-05